Azaspirooctane-carboxylates as Novel Activators/Modulators of M4 for the Treatment of Alzheimer's Disease and Parkinson's Disease

ACS Med Chem Lett. 2024 Nov 4;15(11):1830-1831. doi: 10.1021/acsmedchemlett.4c00512. eCollection 2024 Nov 14.

Author

Affiliation

¹ Arrival Discovery, LLC, San Diego, California 92128, United States.

PMID: 39563827
PMCID: PMC11571014 (available on 2025-11-14)
DOI: 10.1021/acsmedchemlett.4c00512

Abstract

Novel azaspirooctane-carboxylates are described for potential treatment of Alzheimer's disease and Parkinson's disease, among other conditions.

Published 2024 by American Chemical Society.

Publication types

Editorial